Phil key facts
- Developer of an end-to-end healthcare platform designed to make specialty drugs more available and affordable to consumers.
- It has raised $183.6M; the latest was General Corporate Purpose ($60.0M) in Jul 2025.
- Notable investors include FJ Labs, SV Angel, Kevin Moore, Forerunner Ventures, Hemisphere Ventures — 22 tracked in total.
- Status: Privately Held (backing).
Who backs Phil
22+- ·The complete investor list: 22 names
- ·Watch Phil: the Monday email on marks, rounds and moves
Phil funding rounds
No funding rounds for Phil are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Phil investors
22 investors are on record for Phil, including FJ Labs, SV Angel, Kevin Moore and Forerunner Ventures. By type, the record holds 9 venture capital firms and 3 family offices.
About Phil
Developer of an end-to-end healthcare platform designed to make specialty drugs more available and affordable to consumers. The company's platform connects patients, prescribers, pharmacies, and manufacturers and provides an end-to-end prescription management service as a convenient alternative to traditional pharmaceutical management, enabling patients to get access to low-cost medicines and better outcomes for rare diseases.
- Sector
- Healthcare
- HQ
- Scottsdale, AZ, United States
- Founded
- 2015
- Employees
- 195
- Website
- phil.us/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Phil doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.